APA (7th ed.) Citation

Joseph L. Jilek, Kayla L. Frost, Kevyn A. Jacobus, Wenxi He, Erica L. Toth, Michael Goedken, & Nathan J. Cherrington. (2021). Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity. Elsevier.

Chicago Style (17th ed.) Citation

Joseph L. Jilek, Kayla L. Frost, Kevyn A. Jacobus, Wenxi He, Erica L. Toth, Michael Goedken, and Nathan J. Cherrington. Altered Cisplatin Pharmacokinetics During Nonalcoholic Steatohepatitis Contributes to Reduced Nephrotoxicity. Elsevier, 2021.

MLA (9th ed.) Citation

Joseph L. Jilek, et al. Altered Cisplatin Pharmacokinetics During Nonalcoholic Steatohepatitis Contributes to Reduced Nephrotoxicity. Elsevier, 2021.